IP Library Granted Patent US 6,923,965
Granted Patent B2
US 6,923,965 · App. 10/680,670 · Granted Aug 2, 2005

Modulators of polysaccharides and uses thereof

Assignee: The University of Texas System
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,923,965
App. No.
10/680,670
Granted
Aug 2, 2005
Kind
B2
Abstract

The present invention provides peptides with a specific affinity for glycosaminoglycan molecules. These peptides may have any number of functions, including but not limited to use as inhibitors of glycosaminoglycan-mediated processes, enhancers of glycosaminoglycan-mediated processes, and as molecular probes to identify the presence of a specific glycosaminoglycan. Peptides of the invention may be directed against any glycosaminoglycan, including hyaluronic acid, chondroitin sulfate A, chondroitin sulfate C, dermatan sulfate, heparin, keratan sulfate, keratosulfate, chitin, chitosan 1, and chitosan 2. These isolated peptides may have therapeutic uses in the treatment or prevention of diseases involving infection, inflammatory diseases, cancer, infections, etc. The peptides may also have other biological functions such as contraception.

Claims (11)

1. A method for inhibiting an immune reaction, said method comprising administering a peptide consisting essentially of the amino acid sequence of:

i) (Gly-Ala-His-Trp-Gln-Phe-Asu-Ala-Leu-Thr-Val-Arg (SEQ ID NO:1) or a conservative amino acid substitution thereof at a residue position other than 4,5,6,9, 10 or 11;

ii) Gly-Ala-Ala-Trp-Gln-Phe-Asn-Ala-Leu-Thr-Val-Arg (SEQ ID NO:7) or a conservative amino acid substitution thereof at a residue position other than 4,5,6,9, 10 or 11;

iii) Gly-Ala-His-Trp-Gln-Phe-Ala-Ala-Leu-Thr-Val-Arg (SEQ ID NO:8) or a conservative amino acid substitution thereof at a residue position other than 4,5,6,9, 10 or 11; and

iv) Gly-Ala-His-Trp-Gln-Phe-Asn-Ala-Leu-Thr-Val-Ala (SEQ ID NO:9) or a conservative amino acid substitution thereof at a residue position other than 4,5,6,9, 10 or 11,

wherein the peptide selectively binds hyaluronic acid that inhibits an immune reaction.

2. The method of claim 1 , wherein the immune reaction is cutaneous.

3. The method of claim 1 , wherein the peptide inhibits leukocyte infiltration.

4. The method of claim 1 , wherein said method comprises administering:

a carrier material; and

a said peptide to a subject with an immune reaction.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 19, 2010
From: UNIVERSITY OF TEXAS SW MED CTR/DALLAS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024704/0064 →
CONFIRMATORY LICENSE Recorded Oct 21, 2008
From: UNIVERSITY OF TEXAS SW MEDICAL CENTER AT DALLAS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021711/0635 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2004
From: TAKASHIMA, AKIRA; MUMMERT, MARK E.; MOHAMADZADEH, MANSOUR
To: THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 014399/0659 →
Continuity (3)
Division 0953270900 · Mar 22, 2000
Provisional Application 6012647500 · Mar 26, 1999
Related Publication 20040138105A1 · Jul 15, 2004